Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive liver fat accumulation, which is associated with inflammatory responses and metabolic disruptions that may affect skeletal muscle mass. However, the specific relationship between the systemic immune-inflammation index (SII) and skeletal muscle mass in NAFLD patients remains unclear. We conducted a cross-sectional analysis using data from the 2017 to 2018 National Health and Nutrition Examination Survey. The study comprised 673 adults with confirmed NAFLD who met inclusion criteria and had complete data on SII and skeletal muscle mass. Generalized weighted linear regression models were employed to assess the association, with adjustment for multiple covariates including demographic, socioeconomic, and clinical factors. After controlling for covariates, regression analysis revealed a significant independent negative correlation between SII and muscle mass (β = -0.037, 95% confidence interval [CI] = -0.055 to -0.019, P < .001). Smooth curve analysis indicated an approximately linear relationship, with an inflection point at 536.63 (1000 cells/μL). Subgroup analyses showed more pronounced negative correlations in males (β = -0.045, 95% CI = -0.073 to -0.018, P = .001) and non-Hispanic white individuals (β = -0.129, 95% CI = -0.193 to -0.065, P < .001). Our findings provide evidence of an independent negative association between SII and skeletal muscle mass in NAFLD patients, suggesting that systemic immune inflammation may contribute to muscle loss in this population.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051462
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study

Zhiming Lu, 杨卫华, Xunyuan Wu, Jinian Chen et al.
Medicine
Liver Disease Diagnosis and Treatment
article

Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study

Zhiming Lu, 杨卫华, Xunyuan Wu, Jinian Chen, Xiaoxin Zhang, Xiang Chen
article en

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive liver fat accumulation, which is associated with inflammatory responses and metabolic disruptions that may affect skeletal muscle mass. However, the specific relationship between the systemic immune-inflammation index (SII) and skeletal muscle mass in NAFLD patients remains unclear. We conducted a cross-sectional analysis using data from the 2017 to 2018 National Health and Nutrition Examination Survey. The study comprised 673 adults with confirmed NAFLD who met inclusion criteria and had complete data on SII and skeletal muscle mass. Generalized weighted linear regression models were employed to assess the association, with adjustment for multiple covariates including demographic, socioeconomic, and clinical factors. After controlling for covariates, regression analysis revealed a significant independent negative correlation between SII and muscle mass (β = -0.037, 95% confidence interval [CI] = -0.055 to -0.019, P < .001). Smooth curve analysis indicated an approximately linear relationship, with an inflection point at 536.63 (1000 cells/μL). Subgroup analyses showed more pronounced negative correlations in males (β = -0.045, 95% CI = -0.073 to -0.018, P = .001) and non-Hispanic white individuals (β = -0.129, 95% CI = -0.193 to -0.065, P < .001). Our findings provide evidence of an independent negative association between SII and skeletal muscle mass in NAFLD patients, suggesting that systemic immune inflammation may contribute to muscle loss in this population.

MedicineVol. 105(46)
Fujian Medical University (CN), Fuzhou Second Hospital (CN), Union Hospital (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon